Aleafia Health to Announce Fiscal Year 2022 Fifth Quarter and Year End Results

Rhea-AI Summary

Aleafia Health will announce its Q5 and fiscal year results on June 23, 2022, for the period ending March 31, 2022. A conference call will follow at 8:30 a.m. EST, featuring CEO Tricia Symmes and CFO Matt Sale. Aleafia Health is a federally licensed Canadian cannabis company with three production facilities and a robust product portfolio, including oils and edibles. The company also operates a network of medical cannabis clinics. Investors can access the call via toll-free numbers and a webcast link, with a replay available afterward.

Positive

• Aleafia Health has a diverse portfolio of cannabis products catering to both adult-use and medical markets.
• The company operates the first large-scale, legal outdoor cannabis cultivation facility in Canada.

Negative

• None.

TORONTO, June 15, 2022 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia Health” or the “Company”) will announce on June 23 prior to market open its fifth quarter and fiscal year results for the period ending March 31, 2022. The Company will also host its earnings conference call the same day at 8:30 a.m. EST. The call will be hosted by CEO Tricia Symmes and CFO Matt Sale.

CONFERENCE CALL & WEBCAST
Date: June 23, 2022
Time: 8:30 a.m. EST
USA/Canada Toll-Free Participant Call-in: (866) 679-9046 Passcode: 9492125
International Toll-Free Participant Call-in: (409) 217-8323 Passcode: 9492125

WEBCAST LINK

This conference call will be webcast live over the internet and can be accessed through the link provided above. Audio of the call will be available to participants through both the conference call line and webcast; however, the presentation may only be viewed via the webcast. Participants who miss the live call can view a replay at any time via the link provided.

For Investor & Media Relations:

Matthew Sale, CFO
1-833-879-2533
IR@AleafiaHealth.com
LEARN MORE: www.AleafiaHealth.com

About Aleafia Health:

Aleafia Health, a vertically integrated and federally licensed Canadian cannabis company, owns three licensed cannabis production facilities, including the first large-scale, legal outdoor cultivation facility in Canadian history, and operates a strategically located distribution centre, all in the province of Ontario. The Company produces a diverse portfolio of cannabis derivative products including oils, capsules, edibles, sublingual strips, and vapes, for sale in Canada in the adult-use and medical markets and is pursuing opportunities in select international jurisdictions. The Company owns and operates a virtual network of medical cannabis clinics staffed by physicians and nurse practitioners.

Forward Looking Information

This news release contains forward-looking information within the meaning of applicable Canadian and United States securities laws. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “estimates”, “intends”, “anticipates”, or “believes” or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, including risks contained in the Company’s annual information form filed with Canadian securities regulators available on the Company’s SEDAR profile at www.sedar.com. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company does not undertake any obligation to publicly update such forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

FAQ

When will Aleafia Health announce its fifth quarter and fiscal year results?

Aleafia Health will announce its fifth quarter and fiscal year results on June 23, 2022.

What time is the Aleafia Health earnings conference call?

The earnings conference call is scheduled for June 23, 2022, at 8:30 a.m. EST.

How can I access the Aleafia Health conference call?

You can access the conference call via the toll-free numbers provided or through the webcast link.

Who will host the Aleafia Health earnings call?

The earnings call will be hosted by CEO Tricia Symmes and CFO Matt Sale.

What products does Aleafia Health offer?

Aleafia Health offers a portfolio of cannabis derivative products including oils, capsules, edibles, and vapes.